Apalutamide
Brand name: Erleada
Rank #50 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$369.2M
Total Cost
24,956
Total Claims
$369.2M
Total Cost
888
Prescribers
$15K
Cost per Claim
1,139
Beneficiaries
25,452
30-Day Fills
$416K
Avg Cost/Provider
28
Avg Claims/Provider
Share of Medicare Part D Spending
0.13%
of total Medicare Part D spending
$369.2M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $369.2M total
🔎 Data Overview
Ranked #50 out of 500 drugs tracked by total cost. Apalutamide represents a significant portion of Medicare drug spending.
At $14,794 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $415,771 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $324,148 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Apalutamide
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Gautam Jayram | Urology | Nashville, TN | 313 | $4.8M |
| 2 | Paul Eber | Urology | Germantown, TN | 298 | $4.7M |
| 3 | Ghasoub Harb | Urology | Davenport, IA | 264 | $3.9M |
| 4 | John Shen | Hematology-Oncology | Los Angeles, CA | 235 | $3.5M |
| 5 | Zachary Reardon | Urology | Mobile, AL | 232 | $3.5M |
| 6 | David Morris | Urology | Hendersonville, TN | 201 | $3.1M |
| 7 | Gordon Brown | Urology | Cherry Hill, NJ | 198 | $2.8M |
| 8 | Christopher Pieczonka | Urology | Syracuse, NY | 189 | $2.8M |
| 9 | Kristie Kokeny | Physician Assistant | New York, NY | 183 | $2.8M |
| 10 | Chad Reichard | Urology | Indianapolis, IN | 173 | $2.6M |
| 11 | Sukumar Ethirajan | Hematology | Overland Park, KS | 170 | $2.6M |
| 12 | Edward Mcintire | Urology | Cleveland, TN | 162 | $2.5M |
| 13 | Lawrence Gervasi | Urology | Middleburg Heights, OH | 150 | $2.4M |
| 14 | Scott Farnham | Urology | Carmel, IN | 165 | $2.3M |
| 15 | Tyler Emley | Urology | Rensselaer, IN | 142 | $2.2M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 47 | Macitentan (Opsumit) | $394.6M | 30,889 |
| 48 | Insulin Detemir (Levemir Flexpen) | $376.5M | 548,216 |
| 49 | Aripiprazole (Aripiprazole) | $373.1M | 1,494,971 |
| 50 | Apalutamide (Erleada) | $369.2M | 24,956 |
| 51 | Secukinumab (Cosentyx Sensoready (2 Pens)) | $347.7M | 45,496 |
| 52 | Upadacitinib (Rinvoq) | $346.0M | 51,469 |
| 53 | Abiraterone Acetate (Abiraterone Acetate) | $345.0M | 122,643 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology